The original version of this story appeared in Quanta Magazine. In 1939, upon arriving late to his statistics course at UC Berkeley, George Dantzig—a first-year graduate student—copied two problems ...

“He views those as lives saved, not people killed,” Wiles said of the boat strikes that have, to date, killed 104 U.S.-designated “narco-terrorists” in 28 separate strikes. “He wants to keep on ...

Abstract: In this paper, a robust optimal three-dimensional cooperative guidance law with input saturation is proposed for intelligent aerial vehicles to intercept an unknown maneuvering target. The ...

An upbeat second-quarter earnings report from Oracle wasn’t enough to shake off the artificial-intelligence jitters that have crept into the stock. Oracle ORCL cleared the bar set by Wall Street on ...

Richard Fosu does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

Strategy purchased 10,624 bitcoin for about $963 million last week, lifting its total holdings to 660,624 BTC as shares edged higher alongside a modest rebound in bitcoin prices. Strategy, the largest ...

As mixed games are typically less common then hold’em or Omaha, I appreciate anything which helps proliferate it and gives new players an opportunity to enjoy different variants of poker. Because of ...

When Harmeet Dhillon, the Justice Department’s top civil-rights attorney, sent a letter this summer telling Texas officials that their congressional map was unconstitutional, it set off a nationwide ...

Instead of requiring personalized gene edits for each patient, the new approach could create a standardized method to use for many diseases. By Pam Belluck and Carl Zimmer Gene-editing therapies offer ...

The latest game in the long-running Anno strategy city builder series has had a great launch week—depending on where you're standing, at least. Anno 117: Pax Romana, which released on November 12, has ...

Precision oncology is reshaping cancer care, with genomics increasingly guiding diagnosis and therapeutic decisions. At the heart of this transformation are companion diagnostics (CDx), essential ...